The bio-carbon dioxide (CO2) utilization market is projected to grow from $1.66 billion in 2025 to $3.12 billion by 2030, a 13.5% CAGR, according to The Business Research Company. The sector covers biological, chemical, and physical routes for turning captured CO2 into products like biofuels, bioplastics, chemicals, and food ingredients. Growth drivers include corporate net-zero targets, government climate policy, and cheaper microbial fermentation and metabolic engineering. Recent activity shows the technology moving beyond pilots. Again opened a Copenhagen plant that converts industrial CO2 into acetate and acetic acid without gas pre-treatment. CycleØ acquired Biogasclean to produce e-methane from biogenic CO2. Major players include LanzaTech, Solar Foods, Newlight, and Algenol. Readers should treat the figures as a market research estimate, not a guarantee. The useful signal is the direction: CO2 utilization is shifting from lab work to commercial facilities, with industrial decarbonization as the end use. Watch whether companies can move from demonstration scale to repeatable, cost-competitive production.
